Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

DSLD label record: NMN powder by BulkSupplements.com

This DSLD record lists a BulkSupplements.com powder declaring 250 mg beta-nicotinamide mononucleotide per labelled serving; it is a label declaration only, not evidence of efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
NMN (Nicotinamide Mononucleotide)Original label · NIH DSLD
NMN (Nicotinamide Mononucleotide)

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
100 Gram(s) · 3.5 Ounce(s)
Label serving
250 mg
Servings per container
400
Barcode / SKU
X002NDJ7FR
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Beta-Nicotinamide Mononucleotide250 mg250 mg

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 311130 lists the product NMN (Nicotinamide Mononucleotide) under the brand BulkSupplements.com in powder form. [1]

  2. The label declares 250 mg beta-nicotinamide mononucleotide per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

The source at a glance

Brand
BulkSupplements.com
Form
Powder
Pack contents
100 Gram(s) · 3.5 Ounce(s)
Label serving
250 mg
Ingredients listed
Beta-Nicotinamide Mononucleotide
Record type / format
Dietary supplement label/database record
Scope / context
The described product: BulkSupplements.com NMN powder, DSLD record 311130.
Summary based on
Product label / database record

NMN powder record in the NIH DSLD

The NIH Office of Dietary Supplements lists this entry in its Dietary Supplement Label Database as record 311130. The product label name is NMN (Nicotinamide Mononucleotide), the declared brand is BulkSupplements.com and the physical form on the label is powder. The database places it in the category Non-Nutrient/Non-Botanical. The label entered the database on 2024-04-23; the record notes this is not a product launch date.

Supporting source [1]

Declared ingredient: 250 mg NMN per serving

The only declared ingredient in this record is beta-nicotinamide mononucleotide, listed at 250 mg per labelled serving. This amount is a label fact, not personal dosing advice, and the record supplies no serving recommendation. No independent product testing, price or batch certificate is included.

Supporting source [1]

What this label snapshot does not establish

The record describes label declarations only. Inclusion in the DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The listing is not a study, an independent lab test or an endorsement.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. Label declarations only; no independent testing, price, batch certificate or retail availability is supplied.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
NMN (Nicotinamide Mononucleotide)

BulkSupplements.com · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Brand as declared: BulkSupplements.com
  2. Finding 2 ↑

    Beta-Nicotinamide Mononucleotide: 250 mg per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…